Effective therapeutic use of rituximab in refractory Wegener's granulomatosis.
Ferraro
Alistair J
AJ
Queen Elizabeth Hospital, Department of Nephrology, Birmingham, B15 2TT, UK.
Day
Clara J
CJ
Drayson
Mark T
MT
Savage
Caroline O
CO
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects; D014890:Granulomatosis with Polyangiitis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018655:Lymphocyte Count; D016393:Lymphoma, B-Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab